Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Postoperative Ibuprofen in Pediatric Tonsillectomy
NCT03385057Phase 1Withdrawn
- Sponsor
- Massachusetts Eye and Ear
- Start
- Sep 2018
- Primary completion
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of ibuprofen in postoperative pain (2 arms), sponsored by Massachusetts Eye and Ear. Primary endpoint: Post-tonsillectomy bleeding within 14 days of surgery. Planned start Sep 2018; status: withdrawn.
02
Drugs
ibuprofen
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03385057.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03385057.